Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy.
Kato S, Kim KH, Lim HJ, Boichard A, Nikanjam M, Weihe E, Kuo DJ, Eskander RN, Goodman A, Galanina N, Fanta PT, Schwab RB, Shatsky R, Plaxe SC, Sharabi A, Stites E, Adashek JJ, Okamura R, Lee S, Lippman SM, Sicklick JK, Kurzrock R.
Kato S, et al. Among authors: kim kh.
Nat Commun. 2020 Oct 2;11(1):4965. doi: 10.1038/s41467-020-18613-3.
Nat Commun. 2020.
PMID: 33009371
Free PMC article.